|
| 37925055 | Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization. | Mod Pathol | 2024 |
| 37886874 | Pathogenic germline variants in patients with endometrial cancer of diverse ancestry. | Cancer | 2024 |
| 38049664 | The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance. | Nat Genet | 2024 |
| 38041901 | Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival. | Gynecol Oncol | 2024 |
| 36007103 | High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer. | Clin Cancer Res | 2023 |
| 37587346 | Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers. | Nature | 2023 |
| 37890416 | TERT promoter mutations and gene amplification in endometrial cancer. | Gynecol Oncol | 2023 |
| 37651310 | Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications. | Cancer Discov | 2023 |
| 37607324 | Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma. | J Clin Oncol | 2023 |
| 37087482 | Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: opportunity and challenge. | NPJ Precis Oncol | 2023 |
| 36945540 | Direct prediction of Homologous Recombination Deficiency from routine histology in ten different tumor types with attention-based Multiple Instance Learning: a development and validation study. | medRxiv | 2023 |
| 37245486 | Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma. | Gynecol Oncol | 2023 |
| 36944408 | Detection of Biallelic Loss of DNA Repair Genes in Formalin-Fixed, Paraffin-Embedded Tumor Samples Using a Novel Tumor-Only Sequencing Panel. | J Mol Diagn | 2023 |
| 37443169 | Clinicopathologic and genomic features of lobular like invasive mammary carcinoma: is it a distinct entity? | NPJ Breast Cancer | 2023 |
| 37195235 | A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer. | Clin Cancer Res | 2023 |
| 36744932 | Comprehensive analysis of germline drivers in endometrial cancer. | J Natl Cancer Inst | 2023 |
| 36828363 | NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift. | Mod Pathol | 2023 |
| 36494075 | Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers. | J Thorac Oncol | 2023 |
| 36593350 | Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations. | NPJ Precis Oncol | 2023 |
| 36323507 | <i>KIT</i> genetic alterations in breast cancer. | J Clin Pathol | 2023 |
| 33148628 | Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sites. | J Clin Pathol | 2022 |
| 35411948 | Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix. | J Pathol | 2022 |
| 35764743 | Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer. | Nat Cancer | 2022 |
| 35699480 | Genomic Determinants of Early Recurrences in Low-Stage, Low-Grade Endometrioid Endometrial Carcinoma. | J Natl Cancer Inst | 2022 |
| 35849120 | Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles. | Clin Cancer Res | 2022 |
| 36551247 | Comprehensive Genomic Profiling of Cell-Free Circulating Tumor DNA Detects Response to Ribociclib Plus Letrozole in a Patient with Metastatic Breast Cancer. | Biomolecules | 2022 |
| 36089134 | APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas. | Ann Oncol | 2022 |
| 33830625 | Genomic characterization of small cell carcinomas of the uterine cervix. | Mol Oncol | 2022 |
| 34949653 | Cancer-Causative Mutations Occurring in Early Embryogenesis. | Cancer Discov | 2022 |
| 35145232 | Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression. | Oncogene | 2022 |
| 34969956 | Pancreatoblastomas and mixed and pure acinar cell carcinomas share epigenetic signatures distinct from other neoplasms of the pancreas. | Mod Pathol | 2022 |
| 34961764 | ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment. | Mod Pathol | 2022 |
| 35078243 | ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications. | J Natl Cancer Inst | 2022 |
| 34667028 | Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome. | Clin Cancer Res | 2022 |
| 32889887 | Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation. | Am J Surg Pathol | 2021 |
| 33685991 | Genomic Alterations in <i>PIK3CA</i>-Mutated Breast Cancer Result in mTORC1 Activation and Limit the Sensitivity to PI3Kα Inhibitors. | Cancer Res | 2021 |
| 33674143 | Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women. | Gynecol Oncol | 2021 |
| 33536276 | Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer. | Clin Cancer Res | 2021 |
| 33893322 | Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development. | NPJ Breast Cancer | 2021 |
| 33863915 | TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer. | NPJ Breast Cancer | 2021 |
| 33772212 | Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases. | Mod Pathol | 2021 |
| 34470810 | Correction: Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer. | Clin Cancer Res | 2021 |
| 34819508 | Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors. | NPJ Genom Med | 2021 |
| 34635660 | Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination. | NPJ Breast Cancer | 2021 |
| 34535679 | Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies. | NPJ Breast Cancer | 2021 |
| 34079072 | Histologic and genomic features of breast cancers with alterations affecting the SWI/SNF (SMARC) genes. | Mod Pathol | 2021 |
| 34345644 | Pattern of disease and response to pembrolizumab in recurrent cervical cancer. | Gynecol Oncol Rep | 2021 |
| 34240179 | Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni Syndrome. | J Natl Cancer Inst | 2021 |
| 33429428 | Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial. | J Natl Cancer Inst | 2021 |
| 33318584 | Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations. | Mod Pathol | 2021 |